You are not logged in. Press here to login.


List volumes - List articles in this issue

Short communication

Short Form 36 assessed health-related quality of life after focal spasticity therapy

doi: 10.2340/16501977-0318

Open access


OBJECTIVE: Analysis of the impact of an individualized comprehensive focal spasticity management on health-related quality of life.
DESIGN: Prospective observational and interventional 12-week trial in a single-centre rehabilitation outpatient clinic.
Patients: Forty-one adult patients with upper motor neurone lesions (23 men), mean age 52 (standard deviation 13) years; 27 stroke, 7 cerebral palsy and 7 miscellaneous diagnoses.
METHODS: Patients were assessed using the Short Form 36 (SF-36) Questionnaire before and after intramuscular injections of botulinum toxin type A combined with physical interventions. Spasticity was assessed with the Ashworth Scale (0–4). A verbal scale for patients’ self-report of therapy effect was also used.
RESULTS: Significant improvement was found in 3 of 8 SF-36 health scales: social (p = 0.008) and physical functioning (p = 0.026), and role physical (p = 0.048). Spasticity improved significantly (mean 1.1, p < 0.001). Improvement according to the verbal scale was observed for 57 (86%) indications (overall improvement in 36 patients, 88%).
CONCLUSION: Comprehensive focal spasticity management with botulinum toxin type A intramuscular injections and physical interventions can improve patients’ perceived health-related quality of life in addition to objectively and subjectively measured motor functions.


Ulla Bergfeldt, Camilla Sköld, Per Julin

Related articles

There are no related articles.





There is no supplementary for this article.

Related articles

Click here to show related articles

Print information

Volume 41, Issue 4

DOI: 10.2340/16501977-0318

Pages: 279-281

View at PubMed